RSS   Newsletter   Contact   Advertise with us
Post Online Media

Acasti Pharma appoints Linda O'Keefe as CFO

Acasti PharmaAcasti Pharma, a biopharmaceutical company, announced that Linda O'Keefe has been named chief financial officer.
Article continues below

READ MORE Acasti CFO resigns

Ms. O'Keefe brings to Acasti over 30 years of financial experience in the life sciences, manufacturing and business service sectors.

Prior to joining Acasti, Ms. O'Keefe consulted with various firms after serving as chief financial officer and executive-in-residence for Gryphon Investors, a San Francisco-based private equity firm.

Ms. O'Keefe also served as chief financial officer of Delphi Ventures, a healthcare-focused venture capital firm, and Elevate Ventures; as vice president of finance at Genelabs Technologies and Target Therapeutics; and as controller at Collagen Corporation.

Ms. O'Keefe is an active Certified Public Accountant and Chartered Global Management Accountant in California and Indiana and was formerly an audit senior with Ernst & Young.

Ms. O'Keefe is a member of the American Institute of CPAs, the California and Indiana Societies of CPAs, Association for Corporate Growth, Financial Executives International, and Healthcare Financial Management Association.

She holds a Bachelor of Science in Business from the University of California, Berkeley.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy